Effect of Perception-based Interventions on Public Acceptance of Using Large Language Models in Medicine

December 11, 2025 updated by: Liu Jue, Peking University

Perception-based Interventions Affect Public Acceptance of Using Large Language Models in Medicine: Randomized Controlled Trial

Large language models (LLMs) show promise in medicine, but concerns about their accuracy, coherence, transparency, and ethics remain. To date, public perceptions on using LLMs in medicine and whether they play a role in the acceptability of health care applications of LLMs are not yet fully understood. This study aims to investigate public perceptions on using LLMs in medicine and if interventions for perceptions affect the acceptability of health care applications of LLMs.

Study Overview

Detailed Description

Owing to rapid advances in artificial intelligence, large language models (LLMs) are increasingly being used in a variety of clinical settings such as triage, disease diagnosis, treatment planning, and self-monitoring. Despite their potential, the use of LLMs remains restricted within healthcare settings due to lack of accuracy, coherence, and transparency and ethical concerns. Public perceptions such as perceived usefulness and risks play a crucial role in shaping their attitudes towards artificial intelligence that can either facilitate or hinder its adoption. Yet, to our knowledge, there is lack of awareness about perception-driven interventions in health care and no previous studies have examined whether public perceptions play a role in the acceptability of medical applications of LLMs. Hence, this study aims to investigate public perceptions on using LLMs in medicine and if interventions for perceptions affect the acceptability of health care applications of LLMs.

Study Type

Interventional

Enrollment (Estimated)

3000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing Municipality
      • Beijing, Beijing Municipality, China, 100191
        • Jue Liu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • ≥18 years
  • Capable of completing an online survey
  • Agree to sign an informed consent form

Exclusion Criteria:

  • Unable to answer questions or communicate
  • Not willing to participate in this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
No intervention
Experimental: Perceived benefits of large language models in medicine
Participants were asked to read "In April 2023, Massachusetts General Hospital launched a pilot program utilizing medical LLMs to assist with emergency department triage and initial diagnosis and observed a reduction in patient wait times and an improvement in clinical efficiency."
Participants allocated to the intervention group received perception-based interventions. Interventions for Groups 1-3 were perceived benefits of LLMs in medicine, perceived racial bias in LLMs in medicine, and perceived ethical conflicts in LLMs in medicine, respectively.
Experimental: Perceived racial bias in large language models in medicine
Participants were asked to read "In November 2022, a research team from the University of California, San Francisco found that cutting-edge medical LLMs exhibited racial bias when recommending treatment plans."
Participants allocated to the intervention group received perception-based interventions. Interventions for Groups 1-3 were perceived benefits of LLMs in medicine, perceived racial bias in LLMs in medicine, and perceived ethical conflicts in LLMs in medicine, respectively.
Experimental: Perceived ethical conflicts in large language models in medicine
Participants were required to read "In February 2023, a major European hospital network inadvertently leaked partially anonymized but still sensitive patient data during the testing of medical LLMs due to a system configuration error. Although no direct patient harm occurred, this increased public concerns regarding data privacy and security and compelled relevant institutions to conduct urgent reviews of their data protection measures."
Participants allocated to the intervention group received perception-based interventions. Interventions for Groups 1-3 were perceived benefits of LLMs in medicine, perceived racial bias in LLMs in medicine, and perceived ethical conflicts in LLMs in medicine, respectively.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants who will change their attitudes towards medical applications of large language models
Time Frame: Through study completion, an average of 1 year
Public acceptance of applying large language models to medicine will be categorized into yes, not sure, and no, which will be collected before perception-based interventions and after interventions.
Through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jue Liu, Peking University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 25, 2025

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

December 1, 2025

First Submitted That Met QC Criteria

December 11, 2025

First Posted (Actual)

December 26, 2025

Study Record Updates

Last Update Posted (Actual)

December 26, 2025

Last Update Submitted That Met QC Criteria

December 11, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Perception, Self

Clinical Trials on Perception-based interventions

Subscribe